ApprovalTrail

Approval · Notice of Compliance 3875 · 1997

ROFERON-A: Notice of Compliance 3875

Issued June 16, 1997

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3875
Date
June 16, 1997
Company
Hoffmann-La Roche LimitedMississauga, Ontario, Canada
Product type
Biologic
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Alternate manufacturing site for albumin (human) free formulation, two new strengths of albumin (human) free formulation
Therapeutic class
Biological response modifier

Products in this notice

BrandDINStatus today
ROFERON-A02217015Cancelled Post Market
ROFERON-A02217031Cancelled Post Market
ROFERON-A02231512—
ROFERON-A02217066Cancelled Post Market
ROFERON-A02231511—

Medicinal ingredients